REVIEW OF PATENTING OF NEW TECHNOLOGIES

Patents in Information and Communication Technology (ICT)

Information technology products, such as computers, telecommunications equipment and software, have become a cornerstone of modern life.  The economies of developed and developing countries have benefited greatly from the growth of information technology industries themselves, as well as the enhanced competitiveness most industrial sectors enjoy as a result of adopting information technology.  Critical to the growth of information technology, however, has been intellectual property rights.  Patents, copyrights, designs, trade secrets and trademarks are all used to protect the significant investments that go into information technology products and guarantee future technological developments in this field.

India is well known for its software industry, which has growth exponentially in a short space of time. According to estimates of the National Association of Software and Services Companies (NASSCOM) – the main trade body and chamber of commerce of India’s IT and business process outsourcing industries – the domestic software industry generates annual revenues of around US$60 billion, the bulk of which is exported. The number of ICT-related patents grew steadily from the mid-1990s to 2005, at an average rate of 4.7% a year from 2000. In 2005, more than 50500 international patent applications were filed under the PCT to protect inventions in ICT. The number of ICT-related patents increased more rapidly than the total number of PCT applications: on average, there is a larger proportion of ICT related patents in countries’ patent portfolios. The share of ICT-related patents in total patents taken by countries rose by five percentage points in 2003-05 as compared with the 1995-97 level. This proportion doubled in the BRIICS countries, where 36% of patents filed in 2003-05 were related to ICT. Finland, Singapore, China, the Netherlands, Korea and Japan had a large concentration of ICT related patents compared to all countries, as depicted by the revealed technological advantage index. Over 2003-05, more than 50% of patents taken by China, Finland and Singapore concerned ICT, compared to an average of 35% of total patents.

The United States (35%), Japan (18.6%) and Germany (7.7%) were the leaders in ICT-related patenting under the PCT in 2005. China (4.2%) and Korea (4.6%) were among the top five countries in ICT-related patents. The number of ICT patents has risen strongly in these two countries over the last ten years, with more than 2 000 patents in China and about 2 300 in Korea in 2005. Tokyo is the leading region for ICT-related inventions, contributing to nearly 9 400 ICT patents and 6.8% of all ICT-related patents filed under the PCT. Tokyo is followed by two regions in the United States — San Jose/San Francisco/Oakland in California and New York/Newark/Bridgeport on the east coast. Seoul and the province of Gyeonggi-do in Korea rank fourth, with 4 400 ICT-related patents. The Noord-Brabant region (Netherlands), Ile de France (France) and Oberbayern (Germany) are the top three European regions patenting in ICT. The city of Shenzhen in Guangdong province of China made a spectacular entrance into the top 15 ICT related patenting regions in 2003-05, with 52% of the patents taken for ICT related inventions made in China

Patents in Information and Communication Technologies (ICT) are identified using the International Patent Classification (IPC) system: one or several classification codes are attributed to the patent during the examination process. For emerging technologies, however, a specific category or class might not yet be incorporated into the patent classification system, which makes it difficult to identify the patents related to these technologies ex post. Patents taken in the ICT sector can be split into four fields, based on the following list of IPC codes:

Telecommunications: G01S,G08C,G09C,H01P,H01Q,H01S3/(025,043,063,067,085,0933,0941,103,133,18,19,25),

H1S5,H03B,H03C,H03D, H03H,H03M,H04B,H04J,H04K,H04L,H04M,H04Q.

Consumer electronics: G11B,H03F,H03G,H03J,H04H,H04N,H04R,H04S.

Computers, office machinery:

B07C,B41J,B41K,G02F,G03G,G05F,G06,G07,G09G,G10L,G11C,H03K,H03L.

Other ICT:

G01B,G01C,G01D,G01F,G01G,G01H,G01J,G01K,G01L,G01M,G01N,G01P,G01R,G01V,G01W,G02B6,

G05B,G08G,G09B,H01B11,H01J(11/,13/,15/,17/,19/,21/,23/,25/,27/,29/,31/,33/,40/,41/,43/,45/),H01L.

PATENTS IN NANOTECHNOLOGY

Nanotechnology is the study and use of the unique characteristics of materials at the nanometer scale, between the classical large-molecule level to which traditional physics and chemistry apply and the atomic level in which the bizarre rules of quantum mechanics take effect. A recent study by Bhaven Sampat estimates that more than 3700 nanotechnology patents were issued in the United States between 2001 and 2003. That’s a significant number of patents for a technology that has so far produced few actual products. But, in fact, there are significant reasons to think that Sampat’s numbers understate the pace of nanotechnology patenting.

The number of published patent applications in the United States that include the relevant terms in their

claims has increased dramatically, as the following table demonstrates.

Table 1. Published U.S. Patent Applications in Nanotechnology

Year

Published U.S. Applications

2001

403

2002

1975

2003

2964

2004

3842

Inventive activities in nanotechnology have increased substantially since the end of the 1990s: at 18%, the average annual growth rate in nanotechnology patents filed under the PCT surpasses that of overall PCT applications (12.1%) for the period 1995-2005. Most countries report a significant increase in their shares of nanotechnology in total national patenting in the mid-2000s as compared with the mid-1990s, although nanotechnology patenting remains relatively limited (1.1% of total patents on average). Efforts undertaken in Japan are highlighted by the rise in the number of nanotechnology patents in its portfolio (from 0.1% of all patents in 1995-97 to 1% in 2003-05). Singapore, Ireland, the United States, Japan and Israel have a higher concentration of nanotechnology patents than other countries, with a revealed technological advantage index in nanotechnology ranking from 2.7 (Singapore) to 1.1 (Israel). The European Union, Japan and the United States have contributed to 84% of all nanotechnology patents. The share of nanotechnology patents for inventions made in Japan tripled between 1995 and 2005, reaching 16.7% of all nanotechnology patents in 2005. Korea has also broadly invested in nanotechnology, and is now the fifth-ranked country in nanotechnology-related patenting.

The time for nanotechnology has come and a classic technological revolution is unfolding. According to the National Science Foundation, by 2015 the annual global market for nano-related goods and services will top $1 trillion, making it one of the fastest growing industries in history.

Although the process of converting basic research in nanoscience into viable market products will be long and difficult, governments across the globe are impressed by nanotechnology’s potential and are staking their claims and doling out billions of dollars, euros and yen for research. In 2002, worldwide government funding of research and development in nanotechnology exceeded $2 billion, with the US government alone spending $604 million (it increased to $774 million in 2003). In fact, funding from the US government has surged almost sevenfold in the last six years, starting at $116 million in 1997 to a budgeted $847 for 2004.

Although the US accounts for almost a third of global nanotechnology spending, about 40 countries have set up similar initiatives. In December 2003, the US Congress passed the National Nanotechnology Initiative (NNI) of 2000 into law and recommended appropriating $3.7 billion for the next four years for the creation of the National Nanotechnology Coordination Office along with funding for various federal nanotechnology initiatives and programs.

The European Union has earmarked $1 billion from 2002 to 2006, while Japan has increased funding from $120 million in 1997 to nearly $750 million in 2002. Note that it is impossible to accurately determine the total funding in nanotechnology since these figures do not include private funding. Some additional statistics from Nanotech Report 200322 are summarized below:

Public and private companies will spend close to $3 billion worldwide on nanotechnology R and D in 2003.

The US government has appropriated $2 billion for nanotechnology since 2000, putting it on track to be the largest US government funded science initiative since the Apollo Mission.

Presently, more than 700 companies are involved in nanotechnology.
40,000 US scientists are currently capable of working in nanotechnology.
In the past four years, more than 1,700 small tech jobs have been created from venture capital funding.

$900 million in venture capital funding has gone to nanotechnology startups since 1999, with $386 million invested in 2002.

Nanotechnology patents

To reflect the increasing interest and importance of nanotechnology in patents, the EPO, the JPO and the USPTO have made intensive efforts to improve their respective classification systems and to collect all nanotechnology-related patents within a single class. The EPO defines nanotechnology as follows: the term nanotechnology covers entities with a controlled geometrical size of at least one functional component below 100nm in one or more dimensions susceptible to make physical, chemical or biological effects available which are intrinsic to that size. It covers equipment and methods for controlled analysis, manipulation, processing, fabrication or measurement with a precision below 100nm. In 2003, a nanotechnology working group was created in the EPO to establish a definition and to identify nanotechnology patents through keyword searches, consultation with EPO experts in the field, and peer reviews by external experts. As a result of these endeavours, about 90 000 out of 20 million patents and non-patent literature documents were tagged to class Y01N

PATENTS IN ENVIRONMENT-RELATED TECHNOLOGIES

Investment in clean technologies can help achieve a wide range of environmental objectives, from mitigating climate change, to controlling air and water pollution, and enhancing resource efficiency in general. Patents taken in renewable energy technologies or in techniques for controlling automobile emissions contribute to the development of clean technologies. Patenting of inventions related to renewable energy has grown continuously, especially since the mid-1990s. On average, the proportion of PCT filings to protect renewable energy technologies in all patents increased in most countries, especially the European Union and Japan. However, the level of patenting in renewable energy remains low: about 700 international patent applications were filed in 2005. Three generations of renewable energy technologies can be distinguished (International Energy Agency, 2006): first-generation technologies, which have already reached maturity (hydropower, biomass combustion, geothermal energy); second-generation technologies, which are rapidly evolving (solar energy, wind power, etc.); and third-generation technologies, which are currently under development

(e.g. concentrating solar power, ocean energy, improved geothermal systems, etc.).

Patents in Environment-related technology

Based on an intensive review of literature, a set of keywords were identified and used to determine appropriate IPC codes which relate directly to renewable energy in

Wind: F03D(1/*, 3/*, 5/*, 7/*, 9/*, 11/*), B06L8/00, B63H13/00

Solar: F03G6/*, F24J2/*, F25B27/00, F26B3/28, H01L31/042, H02N6/00, E04D13/18, B60L8/00

Geothermal: F24J003/*, F03G4/*, H02N10/00

Ocean: F03B13/(12-24), F03G7/(05, 04), F03B7/00

Biomass: C10L5/(42-44), F02B43/08, C10L1/14, B01J41/16

Waste: C10L5/(46-48), F25B27/02, F02G5/*, F23G4/46, F01K25/14, C10J3/38, F23G7/10, H01M8/06

Conclusions

The World’s most competitive businesses are built on protected innovations and brands. As exclusive rights to ideas and innovations take up a growing share of company value, patent, trademark and design information is the cornerstone of all corporate strategies.

Nanotechnologies in Food

Product Description
Recent developments in the field of nanotechnology have paved the way for lots of innovation in a number of industrial and consumer sectors, including food and food packaging. Whilst nanofood sector is a relatively new emergent, it is widely expected to grow rapidly in the future. A number of nano-sized additives and supplements for food and healthfood products, and nanotechnology derived food packaging materials, are already available in some countries, and their number is expected to increase in the coming years. Whilst such developments offer enormous benefits to the food sector, they have also raised a number of issues in relation to consumer safety, environmental impacts, and ethical, policy and regulatory aspects. Despite these rapid developments in nanotechnology applications for the food sector, only a few reports and articles are currently available that provide an account of the new developments and the current size of market for nanotechnology products and applications. These also do not provide a critical evaluation of the broader aspects of the technology, such as issues around safety of the products to consumers and the environment, and adequacy of the existing regulatory controls. This book provides a source of much needed and up-to-date information on the products and applications of nanotechnology for the food sector – for scientists, regulators, and consumers alike. It also gives an independent, balanced, and impartial view of the potential benefits as well as risks that nanotechnology applications may bring to the food sector. Whilst providing an overview of the state-of-the-art and foreseeable applications to highlight opportunities for innovation, the book also discusses areas of uncertainty in relation to public perception of the new technological developments, and potential implications for consumer safety and current regulatory controls. The book also discusses the likely public perceptions of nanotechnologies in the light of past technological developments in the food sector, and how the new technology will possibly be regulated under the existing regulatory frameworks.

BUY FROM AMAZON–>> Nanotechnologies in Food

Nanotechnology In Healthcare: Market Outlook For Applications, Tools And Materials, And 40 Company Profiles-Aarkstore Enterprise

This report covers different regional application markets, while evaluating them over the next five years. It provides information about the largest regional markets and factors influencing them, while defining the opportunities they present.

Key features of this report

• •Provides an analysis of market data (revenues) of healthcare nanotechnology applications in North America, Europe, Asia and Rest of World that includes Middle East, Africa, Russia, Latin America and Australia.
• Studies key market drivers and restraints for the main market and evaluation of respective sub segments with respect to market dynamics.
• Discusses drug delivery and formulations, biocompatible implants, regenerative medicine and wound care and diagnostics under the applications market along with related sub segments.

Scope of this report

• Understanding the existing and emerging applications of healthcare nanotechnology and their relative and forecast market sizes
• Understanding the product/technological developments on which the companies are focusing for their growth.
• Understanding the different nanotechnology based tools and their importance in the development of new products and applications

Key Market Issues

• Nanotechnology initiatives by developing countries are helping in the development of new products and applications.
• The delay in commercialization due to strict regulations and manufacturing difficulties is inhibiting product reach.
• Stability of nanoparticles inside the biological tissues is an important issue to be considered to reduce contamination by drugs.
• The development of biodegradable nanostructures will be a growth driver in future since they eliminate the issue of excretion.

Key findings from this report

• The healthcare nanotechnology market growth is largest in North America, at $4.75bn in 2009, followed by Europe at $3.65.
• The nanotechnology drug delivery market is expected to grow at a CAGR of 21.7% for the period 2009-14, to reach almost $16bn by 2014.
• Biocompatible implants and coatings and diagnostics comprise some of the major applications which are estimated to experience high growth between 2009 and 2014, 42% and 21.8% respectively.

Key questions answered

• What are the important healthcare nanotechnology markets and their growth over the period 2009-14?
• What are the major applications that have emerged in different areas such as drug formulations and delivery, biocompatible implants and coatings, regenerative medicines and wound care and diagnostics?
• In which areas are the companies focusing while forming strategic alliances with other industry players?

Table of Contents
Nanotechnology in Healthcare
Executive summary 16
Market overview 16
Healthcare nanotechnology market dynamics 16
Nanomaterials & nanotools for the healthcare market 17
Healthcare nanotechnology application market 18
Company profiles 19
Chapter 1 Market overview 22
Summary 22
Introduction 23
Market definition 23
Healthcare nanotechnology business processes 24
Healthcare nanotechnology applications 24
Healthcare nanotechnology application prospects 25
Opportunity matrix 26
Challenge matrix 28
Patent analysis 29
Chapter 2 Healthcare nanotechnology market dynamics 34
Summary 34
Introduction 35
Regional markets 36
North America 37
Europe 38
Asia 38
RoW 39
Competitive landscape 39
R&D activities by applications 41
New product launches 42
Collaborations & agreements 43
Market drivers 56
Nanotechnology research initiatives in developing nations 56
Innovations are increasing 56
Reduced toxicity 56
Market inhibitors 57
Delay in commercialization 57
Stability and other issues 57
Need for particle evaluation 57
Chapter 3 Nanomaterials & nanotools for the healthcare market 60
Summary 60
Introduction 61
Nanomaterials 61
Nanocapsules 61
Drivers 61
Inhibitors 62
Opportunities 62
Nanoporous materials 63
Drivers 63
Opportunities 63
Quantum dots 63
Drivers 64
Inhibitors 64
Opportunities 64
Nanotubes 65
Drivers 65
Nanowires 65
Drivers 66
Inhibitors 66
Opportunities 66
Dendrimers 67
Drivers 67
Opportunities 68
Monoclonal antibodies 68
Drivers 68
Inhibitors 69
Opportunities 69
Nanocomposites 69
Fullerenes 70
Nanofilms 70
Drivers 71
Inhibitors 71
Opportunities 71
Nanotools 72
Nanoarrays 72
Drivers 72
Inhibitors 73
Opportunities 73
Nanobiochip 74
Drivers 74
Opportunities 75
Nanolithography arrays 75
Drivers 75
Inhibitors 76
Opportunities 76
Computer-assisted drug discovery 77
Nanomass spectrometry 77
Drivers 77
Inhibitors 78
Opportunities 78
Congruent Force Intermolecular Test (nanotype) C-FIT 78
Chapter 4 Healthcare nanotechnology application market 82
Summary 82
Introduction 83
Drug formulation and delivery 83
Formulation 84
Drivers 85
Inhibitors 86
Opportunities 86
Fluorescently encoded microparticles 86
Nanoparticulate formulation/systems 88
Fluoropolymers as material platforms for drug therapy 88
DNA nanoparticle technology to produce DNA drugs 89
Drug profiling using smart materials 90
Supercritical fluids and water based nanomaterials 91
Dendrimer nanotechnology products 92
Potential healthcare nanotechnology drug formulation application 93
Drug delivery 93
Drivers 94
Inhibitors 95
Opportunities 95
Nanoencapsulation using nano-device platform 96
Smart materials for encapsulation 97
Antimicrobial nanoencapsulation 98
Nanoscale cochlear drug delivery 99
Drug delivery using nanoparticles 99
Nanocrystals for drug delivery 102
Drug delivery coatings 103
Nanopores 103
Nanocomposites 104
Nanotransponders 105
Potential applications of healthcare nanotechnology drug delivery 105
Biocompatible implants and coatings 106
Drivers 108
Nanofibers fight immune response 108
Improvement in biocompatibility 108
Optimized coatings 108
Improvement in dental implants 108
Inhibitors 108
Improvement of implant depends upon coatings 108
Possibility of mass poisoning 109
Opportunities 109
Improved brain implants 109
Improvement in process for better coatings 109
Helpful in orthopedic devices 109
Surface modification 109
Device coating 110
Drivers 112
Inhibitors 112
Opportunities 112
Sol-gel coatings 113
Biocompatible nanocoatings 113
Nanoscale plasma coating 113
Light-activated antimicrobials 113
Silver nanoparticles 114
Hydrophobic coatings 114
Multifunctional coatings 114
Anti-fouling nanocoatings 114
Passive hydroxyapatite coating 115
Other protective coatings 115
Implants 116
Drivers 116
Opportunities 117
Potential biocompatible implants applications 117
Life support devices using novel biocompatible polymers 117
Stimulation electrodes using nanotechnology 117
Noninvasive killing of cancer cells using localized heat 118
Artificial vascular grafts 118
Bone graft substitutes 118
Regenerative medicine and wound care 118
Regenerative medicine/tissue engineering 119
Drivers 120
Inhibitors 121
Opportunities 121
Potential applications of regenerative medicines 123
Wound care 124
Drivers 124
Opportunities 125
Nanosilver gels 125
Nanogold gels 125
Diagnostics 126
Drivers 127
Improved bioassays 127
Earlier diagnosis and effective monitoring 127
Opportunities 127
Treatment of ovarian cancer 127
Development of immunoassays 128
Quantum dots applications 128
Nanoemulsions in multimodal molecular imaging and targeted therapeutics 128
Nanoparticles for biochemical applications 129
Magnetic nanoparticles for medical diagnostic imaging 129
Encapsulation of radioactive nanoparticle 129
Genome sequencing 129
Nanobiosensors 130
Nanoarray biochips 130
Silicon-based chips/sensors for pH and pressure 130
Micro- and nano-replication for point-of-use analytical applications 131
Nanocells 131
Redox enzymes 131
Other potential diagnostics applications 132
Smart card diagnostics 132
Novel microfluidic technologies 132
Chapter 5 Company profiles 134
Summary 134
Abraxis BioScience, Inc. 135
Company overview 135
Products and services 135
Company strategy 136
Access Pharmaceuticals, Inc. 137
Company overview 137
Products and services 137
Company strategy 138
AstraZeneca 138
Company overview 138
Products and services 139
Company strategy 139
AMAG Pharmaceuticals, Inc. 139
Company overview 139
Products and services 140
Company strategy 140
Aphios Corp. 140
Company overview 141
Products and services 141
Company strategy 142
Asklepios Biopharmaceutical Inc. 142
Company overview 143
Products and services 143
Company strategy 143
Capsulution Nanoscience AG 144
Company overview 144
Products and services 144
Company strategy 144
ConvaTec 145
Company overview 145
Products and services 145
Company strategy 146
Debiotech 146
Company overview 146
Products and services 146
Company strategy 147
Do-Coop Technologies Ltd. 147
Company overview 147
Products and services 147
Company strategy 148
Elan Corp. 148
Company overview 148
Products and services 148
Company strategy 149
Ferro Corp. 149
Company overview 149
Products and services 150
Company strategy 150
Flamel Technologies 150
Company overview 151
Products and services 151
Company strategy 151
GE Global Research 152
Company overview 152
Company strategy 152
GfE Medizintechnik GmbH 153
Company overview 153
Products and services 153
Company strategy 154
HemCon Medical Technologies, Inc. 154
Company overview 154
Company strategy 155
iCeutica Inc 155
Company overview 155
Products and services 156
Company strategy 156
Liquidia Technologies 157
Company overview 157
Company strategy 157
Luna Innovations Inc. 158
Company overview 158
Products and services 158
Company strategy 159
MagForce Nanotechnologies AG 159
Company overview 160
Products and services 160
Company strategy 161
Merck KGaA 161
Company overview 161
Products and services 162
Company strategy 162
MIV Therapeutics Inc 162
Company overview 163
Products and services 163
Company strategy 163
Nanomix 163
Company overview 164
Products and services 164
Company strategy 164
Nano Interface Technology, Inc 165
Company overview 165
Products and services 165
Company strategy 165
NanoCarrier Co., Ltd. 165
Company overview 166
Products and services 166
Company strategy 166
NanoDel Technologies 167
Company overview 167
Products and services 167
Company strategy 167
NanoHorizons Inc. 168
Company overview 168
Products and services 168
Company strategy 168
Nanoprobes, Inc. 169
Company overview 169
Products and services 169
Company strategy 169
Nanospectra Biosciences Inc. 170
Company overview 170
Products and services 170
Company strategy 170
Nanosphere, Inc. 171
Company overview 171
Products and services 171
Company strategy 172
Novartis AG 172
Company overview 173
Products and services 173
Company strategy 173
Pfizer 173
Company overview 173
Company strategy 174
PharmaSol GmbH 174
Company overview 174
Products and services 174
Company strategy 175
Pioneer Surgical Technology 175
Company overview 175
Products and services 175
Company strategy 176
pSivida 176
Company overview 176
Products and services 176
Company strategy 176
F. Hoffmann–La Roche Ltd. 177
Company overview 177
Products and services 177
Company strategy 177
Siemens Medical Solutions 178
Company overview 178
Products and services 179
Company strategy 179
Smith & Nephew 179
Company overview 179
Products and services 180
Company strategy 180
Starpharma Holdings Ltd. 181
Company overview 181
Products and services 181
Company strategy 182
T2 Biosystems Inc. 183
Company overview 183
Company strategy 183
Appendix 184
Patents 184
Glossary 218

List of Figures
Figure 1.1: Global healthcare nanotechnology market 23
Figure 1.2: Geographical patent share, 2003-08 30
Figure 1.3: Number of patents by region, 2003-09 30
Figure 1.4: Comparison of patent trends, 2004 vs 2009 31
Figure 2.5: Developmental strategies by major players, January 2007–November 2009 40
Figure 2.6: R&D activities by applications, Jan 2007–Nov 2009 41
Figure 2.7: New product launches, Jan 2007–Nov 2009 42
Figure 2.8: Collaborations & agreements by applications, Jan 2007–Nov2009 43
Figure 2.9: Relative importance of features of healthcare nanotechnology 58

List of Tables
Table 2.1: Global healthcare nanotech market, by geography ($m), 2007-14 37
Table 2.2: Mergers & acquisitions in healthcare nanotech market, 2007–09 44
Table 2.3: New product launches in healthcare nanotech market, 2007–09 45
Table 2.4: New product launches in healthcare nanotech market, 2007–09 (ctd) 46
Table 2.5: R&D in healthcare nanotech market, 2007–09 47
Table 2.6: R&D in healthcare nanotech market, 2007–09 (ctd 1) 48
Table 2.7: R&D in healthcare nanotech market, 2007–09 (ctd 2) 49
Table 2.8: R&D in healthcare nanotech market, 2007–09 (ctd 3) 50
Table 2.9: R&D in healthcare nanotech market, 2007–09 (ctd 4) 51
Table 2.10: R&D in healthcare nanotech market, 2007–09 (ctd 5) 52
Table 2.11: R&D in healthcare nanotech market, 2007–09 (ctd 6) 53
Table 2.12: Collaborations & agreements in healthcare nanotech market, 2007–09 54
Table 2.13: Collaborations & agreements in healthcare nanotech market, 2007–09 (ctd) 55
Table 4.14: Global healthcare nanotech drug formulation and delivery market, by product ($m), 2007–14 83
Table 4.15: Global healthcare nanotech drug formulation and delivery market, by geography ($m), 2007–14 84
Table 4.16: Global healthcare nanotechnology drug formulation market, by product ($m), 2007–14 85
Table 4.17: Global healthcare nanotech fluorescently encoded microparticles market, by geography ($m), 2007–14 87
Table 4.18: Global healthcare nanotech nanoparticulate formulation/systems market, by geography ($m), 2007–14 88
Table 4.19: Global healthcare nanotech fluoropolymers material platforms for drug therapy market, by geography ($m), 2007–14 89
Table 4.20: Global healthcare DNA nanoparticle technology to produce DNA drugs market, by geography ($m), 2007-14 90
Table 4.21: Global healthcare nanotech drug profiling using smart materials market, by geography ($m), 2007-14 91
Table 4.22: Global healthcare nanotech supercritical fluids and water based nanomaterials market, by geography ($m), 2007-14 91
Table 4.23: Global dendrimer nanotech products market by geography ($m), 2007-14 92
Table 4.24: Global healthcare nanotech drug delivery market by product ($m), 2007-14 94
Table 4.25: Global healthcare nanoencapsulation using nano-device platform market, by product ($m), 2007-14 96
Table 4.26: Global healthcare nanoencapsulation using nano-device platform market, by geography ($m), 2007-14 97
Table 4.27: Global market for smart materials encapsulating pharmaceuticals, by geography ($m), 2007-14 98
Table 4.28: Global healthcare nanotech antimicrobial nanoencapsulation, by geography ($m), 2007-14 98
Table 4.29: Global healthcare nanotech nanoscale cochlear drug delivery, by geography ($m), 2007-14 99
Table 4.30: Global healthcare nanotech drug delivery using nanoparticles market, by product ($m), 2007-14 100
Table 4.31: Global healthcare nanotech drug delivery using nanoparticles market, by geography ($m), 2007-14 100
Table 4.32: Global drug delivery using nanocrystals market, by geography ($m), 2007-14 102
Table 4.33: Global healthcare nanotech drug delivery coatings market, by geography ($m), 2007- 14 103
Table 4.34: Global healthcare nanopores market, by geography ($m), 2007-14 104
Table 4.35: Global healthcare nanocomposites market, by geography ($m), 2007-14 104
Table 4.36: Global healthcare nanotech nanotransponder market, by geography ($m), 2007-14 105
Table 4.37: Global healthcare nanotech biocompatible implants and coatings market, by products ($m), 2007-14 107
Table 4.38: Global healthcare nanotech biocompatible implants and coatings market, by geography ($m), 2007-14 107
Table 4.39: Global healthcare nanotech surface modification market, by geography ($m), 2007-14 110
Table 4.40: Global healthcare nanotech device coating market, by products ($m), 2007-14 111
Table 4.41: Global healthcare nanotech device coating market, by geography ($m), 2007-14 111
Table 4.42: Global healthcare nanotech implants market, by geography ($m), 2007-14 116
Table 4.43: Global healthcare nanotech regenerative medicine and wound care market, by products
($m), 2007-14 119
Table 4.44: Global healthcare nanotech regenerative medicine market, by product ($m), 2007-14 120
Table 4.45: Global healthcare nanotech wound care market, by products ($m), 2007-14 124
Table 4.46: Global healthcare nanotech diagnostics market, by products ($m), 2007-14 126
Table 4.47: Global healthcare nanotech diagnostics market, by geography ($m), 2007-14 127
Table 0.48: US patents 184
Table 0.49: US patents (ctd 1) 185
Table 0.50: US patents (ctd 2) 186
Table 0.51: US patents (ctd 3) 187
Table 0.52: US patents (ctd 4) 188
Table 0.53: US patents (ctd 5) 189
Table 0.54: US patents (ctd 6) 190
Table 0.55: US patents (ctd 7) 191
Table 0.56: US patents (ctd 192
Table 0.57: US patents (ctd 9) 193
Table 0.58: US patents (ctd 10) 194
Table 0.59: US patents (ctd 11) 195
Table 0.60: US patents (ctd 12) 196
Table 0.61: US patents (ctd 13) 197
Table 0.62: US patents (ctd 14) 198
Table 0.63: US patents (ctd 15) 199
Table 0.64: US patents (ctd 16) 200
Table 0.65: US patents (ctd 17) 201
Table 0.66: US patents (ctd 18) 202
Table 0.67: US patents (ctd 19) 203
Table 0.68: Europe patents 204
Table 0.69: Europe patents (ctd 1) 205
Table 0.70: Europe patents (ctd 2) 206
Table 0.71: Europe patents (ctd 3) 207
Table 0.72: Europe patents (ctd 4) 208
Table 0.73: Europe patents (ctd 5) 209
Table 0.74: Europe patents (ctd 6) 210
Table 0.75: Europe patents (ctd 7) 211
Table 0.76: Europe patents (ctd 212
Table 0.77: Europe patents (ctd 9) 213
Table 0.78: Europe patents (ctd 10) 214
Table 0.79: Europe patents (ctd 11) 215
Table 0.80: Japan patents 216
Table 0.81: Japan patents (ctd 1) 217
 
For More information please contact :

  
http://www.aarkstore.com/reports/Nanotechnology-in-Healthcare-Market-outlook-for-applications-tools-and-materials-and-40-company-profiles-38032.html 

 

Nanofuture: What’s Next For Nanotechnology

• ISBN13: 9781591022879
• Condition: NEW
• Notes: Brand New from Publisher. No Remainder Mark.

Product Description
Flying cars, space travel for everyone, the elimination of poverty and hunger, and powerful new tools to combat disease, and even aging. These are some of the amazing predicted developments of nanotechnology, the coming science of designing and building machines at the molecular and atomic levels. Will this new scientific revolution be for better or worse? Some commentators have described utopias; others have prophesied disaster. Find out the likely reality from an expert, Dr. J. Storrs Hall, in this absorbing insider’s guide to the near future. Dr. Hall—a leading researcher on the frontiers of nanotechnology who has designed for NASA—describes nanotechnology in a very accessible way, so that anyone can understand what it’s about, what it could do, and what it can’t do. He puts it into historical context, explaining how previous technological developments have affected us, how nanotechnology fits into the historical trends for technologies ranging from motors to medicine, and how the continuation of these trends, with nanotechnology as a strong determining factor, will have a profound impact on the future. In addition to describing his famous invention utility fog, Hall explains how nanotechnology will make possible many of the science fiction dreams of the past. But what hurdles, technological, political, or social, stand in the way? What dangers will this powerful new technology pose? How will it impact the environment? Can we afford to develop it? Can we afford not to? The true dangers are not what you may think, and are far different from the fears of today’s alarmists. In a straightforward, balanced manner, Dr. Hall analyzes the benefits as well as the potential risks. Together with its sister science of biotechnology, nanotechnology has the potential to alter the very human race, change who we are. Can this possibly be good? Should it be encouraged or opposed? No one knows for sure, but the basis for informed thought can be found in these exciting, stimulating pages, which will open the doors of the future to you.

BUY FROM AMAZON–>> Nanofuture: What’s Next For Nanotechnology

« Previous Page